Related Experiment Video
Updated: Dec 2, 2025
09:32
Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
Published on: September 19, 2018
15.7K
Beta-Blockers and Abdominal Aortic Aneurysm Growth: A Systematic Review and Meta-Analysis
1Department of Internal Medicine, Banner-University Medical Center, University of Arizona, 1501 N Campbell Ave, Tucson, AZ 85719, United States.
Current Cardiology Reviews
|November 4, 2020
Summary
Beta-blockers do not significantly slow aortic aneurysm growth. This meta-analysis found no evidence that these drugs reduce aneurysm expansion, highlighting the need for alternative medical therapies.
Area of Science:
- Cardiovascular Medicine
- Medical Research
Background:
- Aortic aneurysms pose significant risks, including dissection and rupture.
- Beta-blockers are a common first-line treatment for aortic aneurysms.
- The efficacy of beta-blockers in managing aortic aneurysm growth requires further investigation.
Purpose of the Study:
- To evaluate the impact of beta-blockers on aortic aneurysm growth rates.
- To synthesize evidence from clinical trials comparing beta-blockers to placebo for aortic aneurysm management.
Main Methods:
- A systematic literature search identified relevant clinical trials.
- Meta-analysis employed a random-effects model.
- Aortic aneurysm growth rate per year was the primary endpoint.
Main Results:
- Eight clinical trials were included in the meta-analysis.
- Beta-blockers demonstrated a statistically non-significant effect on aortic aneurysm growth.
- The standard mean difference for growth rate was -0.44 (95% CI [-0.44, 0.00]).
Conclusions:
- Beta-blockers do not significantly influence the growth rate of aortic aneurysms.
- Current evidence does not support beta-blockers for reducing aortic aneurysm expansion.
- Further research is needed to identify effective medical therapies for aortic aneurysm growth.
